The University of Western Australia, Perth, WA, Australia.
Perth Children's Hospital, Perth, WA, Australia.
JBI Evid Synth. 2022 Nov 1;20(11):2656-2696. doi: 10.11124/JBIES-21-00182.
This review aimed to describe the scope and operational features of anaphylaxis registries, and to assess their contribution to improving knowledge of anaphylaxis and care of patients who experience anaphylaxis by measuring their research output.
Structured data collection and reporting systems, such as registries, are needed to better understand the burden of anaphylaxis and to protect the growing number of patients with severe allergy. There is a need to characterize current anaphylaxis registries to identify their value in anaphylaxis surveillance, management, and research. Information synthesized in this review will provide knowledge on benefits and gaps in current registries, which may inform the implementation and global standardization of future anaphylaxis reporting systems.
This scoping review considered literature describing registries worldwide that enroll patients who have experienced anaphylaxis. Published and gray literature sources were included if they described the scope and operational features of anaphylaxis registries.
This review followed the JBI methodology for scoping reviews. Embase, MEDLINE, Scopus, and CINAHL were searched for relevant articles. Identified keywords and index terms were adapted for searches of gray literature sources, using Google advanced search functions. Only full-text studies in English were considered for inclusion. Two independent reviewers conducted title and abstract screening and those that did not meet the inclusion criteria were excluded. The full text of potentially relevant articles were retrieved; full-text screening and data extraction were also conducted by two independent reviewers. Any discrepancies were resolved through discussion or with a third reviewer. Tables and a narrative summary were used to describe and compare the scope and features (eg, inclusion criteria, patient demographics, clinical symptoms) of the identified anaphylaxis registries, and to outline their output to assess their contribution to research and clinical practice for anaphylaxis.
A total of 77 full-text publications and eight gray literature sources were used to extract data. The literature search identified 19 anaphylaxis registries, with sites in 28 countries including Europe, the United Kingdom, Canada, the United States, Korea, and Australia. The main purposes of the identified registries were to collect clinical data for research; provide clinical support tools to improve patient care; and operate as allergen surveillance systems to protect the wider community with allergies. Differences in inclusion and health care settings exist, with 11 collecting data on anaphylaxis of any cause, two on food reactions alone, three on fatal anaphylaxis, one on perioperative anaphylaxis, and two on allergic reactions (including anaphylaxis). Five registries enroll cases in allergy centers, five in hospital settings, one in schools, and others target a combination of general practitioners, specialists in emergency departments, and other relevant hospital departments and allergy outpatient clinics. Only three registries operate under a mandatory framework. A total of 57 publications were considered research outputs from registries. All registries except two have published studies from collected data, with the greatest number of articles published from 2019 to the present. Publications mostly addressed questions regarding demographic profile, causes and cofactors, severity, fatal reactions, and gaps in management.
This review demonstrated that anaphylaxis registries differ in their scope and operation, having been established for different purposes. Importantly, registries have contributed significantly to research, which has highlighted gaps in anaphylaxis management, provoking allergens, and informed targets for prevention for severe and fatal events. Beyond this, registries relay information about anaphylaxis to clinicians and regulatory bodies to improve patient care and protect the community. The ability to link registry data with other health datasets, standardization of data across registries, and incorporation of clinical care indicators to promote quality health care across the health system represent important targets for future systems.
本综述旨在描述过敏反应登记处的范围和运作特点,并通过评估其研究成果来衡量其对改善过敏反应知识和过敏反应患者护理的贡献。
为了更好地了解过敏反应的负担并保护越来越多的严重过敏患者,需要建立结构化的数据收集和报告系统,如登记处。有必要对当前的过敏反应登记处进行特征描述,以确定其在过敏反应监测、管理和研究中的价值。本综述综合的信息将提供关于当前登记处的益处和差距的知识,这可能为未来过敏反应报告系统的实施和全球标准化提供信息。
本范围综述考虑了全球范围内招募经历过过敏反应的患者的登记处文献。如果描述了过敏反应登记处的范围和运作特点,发表的和灰色文献来源也包括在内。
本综述遵循 JBI 用于范围综述的方法。在 Embase、MEDLINE、Scopus 和 CINAHL 中搜索相关文章。适应了关键词和索引术语,以使用 Google 高级搜索功能搜索灰色文献来源。仅考虑全文为英文的研究。两名独立的审查员进行标题和摘要筛选,不符合纳入标准的文章将被排除。可能相关的文章的全文被检索;两名独立的审查员还进行了全文筛选和数据提取。任何分歧都通过讨论或第三名审查员解决。使用表格和叙述性摘要来描述和比较确定的过敏反应登记处的范围和特征(例如,纳入标准、患者人口统计学、临床症状),并概述其研究成果,以评估其对过敏反应研究和临床实践的贡献。
共使用 77 篇全文出版物和 8 篇灰色文献来源提取数据。文献检索确定了 19 个过敏反应登记处,其所在地包括欧洲、英国、加拿大、美国、韩国和澳大利亚的 28 个国家。确定的登记处的主要目的是为研究收集临床数据;提供改善患者护理的临床支持工具;并作为过敏原监测系统,以保护更广泛的过敏社区。纳入和医疗保健环境存在差异,其中 11 个登记处收集任何原因的过敏反应数据,2 个登记处仅收集食物反应数据,3 个登记处收集致命过敏反应数据,1 个登记处收集围手术期过敏反应数据,2 个登记处收集过敏反应(包括过敏反应)数据。5 个登记处招募过敏中心的病例,5 个登记处招募医院的病例,1 个登记处招募学校的病例,其他登记处的目标是综合全科医生、急诊科专家以及其他相关医院科室和过敏门诊诊所。只有 3 个登记处在强制性框架下运作。共有 57 篇出版物被认为是登记处的研究成果。除了两个登记处之外,所有登记处都发表了从收集的数据中得出的研究结果,从 2019 年至今发表的文章数量最多。出版物主要解决了关于人口统计学特征、原因和促成因素、严重程度、致命反应和管理差距的问题。
本综述表明,过敏反应登记处的范围和运作存在差异,其建立目的也不同。重要的是,登记处对研究做出了重大贡献,突出了过敏反应管理、引发过敏原和针对严重和致命事件的预防目标方面的差距。除此之外,登记处还向临床医生和监管机构传达过敏反应信息,以改善患者护理并保护社区安全。将登记处数据与其他健康数据集链接的能力、跨登记处的数据标准化以及纳入临床护理指标以促进整个医疗系统的高质量医疗保健,是未来系统的重要目标。